BELLEROPHON THERAPEUTICS INC's ticker is BLPH and the CUSIP is 078771300. A total of 23 filers reported holding BELLEROPHON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $57,974 | -42.4% | 145,810 | 0.0% | 0.00% | – |
| Q2 2023 | $100,609 | -91.3% | 145,810 | 0.0% | 0.00% | – |
| Q1 2023 | $1,150,441 | +776.7% | 145,810 | 0.0% | 0.00% | – |
| Q4 2022 | $131,229 | -65.1% | 145,810 | -57.8% | 0.00% | – |
| Q3 2022 | $376,000 | -15.1% | 345,194 | -4.3% | 0.00% | – |
| Q2 2022 | $443,000 | -48.0% | 360,790 | 0.0% | 0.00% | – |
| Q1 2022 | $852,000 | -25.8% | 360,790 | -2.6% | 0.00% | – |
| Q4 2021 | $1,148,000 | -17.2% | 370,553 | +8.5% | 0.00% | – |
| Q3 2021 | $1,387,000 | -15.0% | 341,455 | +1.3% | 0.00% | – |
| Q2 2021 | $1,632,000 | -12.4% | 336,966 | -6.2% | 0.00% | – |
| Q1 2021 | $1,864,000 | -25.8% | 359,159 | -4.6% | 0.00% | – |
| Q4 2020 | $2,512,000 | -30.2% | 376,588 | +6.5% | 0.00% | – |
| Q3 2020 | $3,601,000 | -19.6% | 353,722 | -0.9% | 0.00% | – |
| Q2 2020 | $4,478,000 | +438.2% | 356,785 | +370.0% | 0.00% | – |
| Q1 2020 | $832,000 | – | 75,910 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PFS Partners, LLC | 6,000 | $2,386 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 383,178 | $152 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 113,911 | $45,291 | 0.00% |
| OSAIC HOLDINGS, INC. | 557 | $221 | 0.00% |
| US BANCORP \DE\ | 1,221 | $485 | 0.00% |
| WELLS FARGO & COMPANY/MN | 180,066 | $71,594 | 0.00% |
| NORTHERN TRUST CORP | 30,251 | $12,028 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 2,100 | $840 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 95,656 | $38,262 | 0.00% |